Ergoteles’s Repare Therapeutics RPTX Stock Holding History

Ergoteles’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,602	Closed	-$278K	–	1543
2021 Q3	$278K	Buy	+10,602	New	+$342K	0.01%	837

Other funds holding RPTX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Ergoteles's RPTX Position: Q4 2021 in Review

Ergoteles sold out of Repare Therapeutics (RPTX) in Q4 2021, closing a stake of 10,602 shares — an estimated $278K sold.

Ergoteles first reported a position in RPTX in Q3 2021 and held it in 1 quarter. The position peaked at $278K in Q3 2021. 67 funds tracked by Wall St. Rank hold RPTX as of Q4 2021.

Ergoteles reported no remaining Repare Therapeutics position as of Q4 2021 after selling out during the quarter.
Ergoteles sold 10,602 Repare Therapeutics shares in Q4 2021, an estimated $278K.
Ergoteles first reported a position in Repare Therapeutics in Q3 2021 and held it in 1 quarter.
Ergoteles's Repare Therapeutics position peaked at $278K in Q3 2021.
67 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.